Background We performed a nationwide population-based retrospective study to describe
the epidemiology of bacterial co-infections in coronavirus disease 2019 (COVID-19) …

Objectives To describe the burden, epidemiology and outcomes of co-infections and
superinfections occurring in hospitalized patients with coronavirus disease 2019 (COVID …

Purpose The goal of our review was to gather information on the most important community-
acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) …

Objectives We described the current incidence and risk factors of bacterial co-infection in
hospitalized patients with COVID-19. Methods Observational cohort study was performed at …

Purpose To investigate antimicrobial use and primary and nosocomial infections in
hospitalized COVID-19 patients to provide data for guidance of antimicrobial therapy …

Background We defined the frequency of respiratory community-acquired bacterial co-
infection in patients with COVID-19, ie patients with a positive SARS-CoV-2 PCR or a COVID …

Introduction. During previous viral pandemics, reported co-infection rates and implicated
pathogens have varied. In the 1918 influenza pandemic, a large proportion of severe illness …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Background: We sought to determine the incidence of community-onset and hospital-
acquired coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19) and …

The prevalence of patients hospitalized in ICUs with COVID-19 and co-infected by
pathogenic bacteria is relevant in this study, considering the integrality of treatment. This …